Condition: Diffuse Large B Cell Lymphoma (DLBCL) · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Acute Lymphoblastic Leukemia (ALL) · Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
The aim of this Study is the evaluation of post-infusion CAR-T (Chimeric Antigen Receptor T Cell) expansion and persistence in patients with DLBCL, PMBCL and ALL undergoing CAR-T therapy; and the feasibility and efficacy of the treatment in the real life practice.
This description comes directly from the study's public registry record.
Domenico Russo, MD · 00390303996811 · domenico.russo@unibs.it
Mirko Farina, MD · 00390303996811 · m.farina004@unibs.it
Always discuss trial participation with your own doctor first.
| ASST Spedali Civili di Brescia | Brescia, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05366569